Joana Goncalves
CIK 1756991 · Chief Medical Officer · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.33M
Companies
2
Total Filings
43
Lifetime Open-Market Net
-$2.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | Chief Medical Officer | 33,377 | $69.89 | $2.33M | -$1.87M | 8 | 2026-05-15 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | CHIEF MEDICAL OFFICER | 53,365 | $15.96 | $851.7K | -$942.1K | 35 | 2024-04-09 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-12 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −7,770 | -$4.1K | EDGAR |
| 2024-02-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +13,500 | $0 | EDGAR |
| 2023-06-27 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,723 | -$9.6K | EDGAR |
| 2023-04-06 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,481 | -$12.2K | EDGAR |
| 2023-03-07 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −6,221 | -$60.4K | EDGAR |
| 2023-03-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-17 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,265 | -$23.1K | EDGAR |
| 2023-01-19 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,265 | -$24.5K | EDGAR |
| 2023-01-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,265 | -$23.1K | EDGAR |
| 2022-12-23 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,992 | -$33.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.